Home -> Law Blog Directory -> Patent Law Blogs -> IPBiz
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: IPBizEPO/EBA to review WARF stem cell applications on 24-25 June
By Lawrence B. Ebert, Esq.
The groups said the patents' dubious validity is underscored by the fact that no other country in the world honors them. As a result, U.S. researchers have sent research monies abroad where they can avoid paying royalties to WARF. California voters approved the nation's largest publicly funded stem cell research program in 2004 with Proposition 71, which allocated $3 billion in grants over the next 10 years. More information about FTCR and PUBPAT's challenges to the WARF stem cell patents (U.S. Patents Nos. 5,843,780, 6,200,806 and 7,029,913), including copies of the Patent Office's Orders rejecting the patents, can be found at http://www.pubpat.org/warfstemcell.htm.
On 24-25 June 2008, there are public oral proceedings before the Enlarged Board of Appeal of the European Patent Office (EBoA) over the WARF patent applications before the EPO.
Of the past, the EPO notes:
On 13 July 2004, an EPO Examining Division refused to grant a patent for the application on the grounds that it was found to be not consistent with the European Patent Convention (EPC), which regulates and harmonises patent practice across Europe. One of the main reasons for the refusal was that the disclosed method of obtaining stem cells used as the starting material a primate (including human) embryo which was destroyed in the process. Somehow, John Simpson neglected to mention this in his attacks on the WARF patents.
The FTCR/PubPat re-examination challenge to the U.S. WARF patents went down in flames. The references they cited were deemed non-enabled, and the declarations were found conclusionary.
See also
http://ipbiz.blogspot.com/2008/03/sciencetoday-on-warf-victories-over.html
http://ipbiz.blogspot.com/2008/03/warf-smokes-pubpat-ftcr-in-last-two-re.html
Full post as published by IPBiz on June 24, 2008 (boomark / email).
Cell Phone Early Termination Fees
How to recover billing errors
New Study Links Cell Phone Radiation to Increased Health Risks
Cell Phone Radiation Is Your Phone Toxic?
Federal Government
Florida residents sue claiming extraordinary delays in judging citizenship applications.
Verizon Settles Cell Phone Billing Class Action for $90 Million
Verizon Settles Cell Phone Class Action for $90 Million
FDA Issues Update on Safety Review Orlistat
Orlistat FDA Issues Update on Safety Review
Aurora Loan Faces Class Action over Mortgage Review Services
Aurora Loan Faces Class Action over Mortgage Review Services
Samsung
Recalls Jitterbug Cell Phones

Ding! WARF Wins Round 2 As Stem Cell Patent Upheld
Yes, It IS Time (Finally) to Stop the Hypocrisy over Human Stem Cell Patents
Law and Public Policy for the Stem Cell Century
WARF Licenses Stem Cell Patent Portfolio to BioTime







